How has CONMED's unrealized gains (losses) on hedge instruments changed year-over-year?

CONMED's unrealized gains (losses) on hedge instruments increased by 183.4% year-over-year, from -$3.67M to $3.06M.

CONMED CNMD Unrealized gains (losses) on hedge instruments

Unrealized gains (losses) on hedge instruments at other companies

TFX

TeleflexTFX

$1.45M+169%

MedtronicMDT

——

Intuitive SurgicalISRG

——

GE HealthCare TechnologiesGEHC

——

Other financials

Income statement

See full

Revenue$317.0M-1.3%

Gross profit$183.4M+3.2%

Operating income$25.4M+59.3%

Net income$13.8M+129%

EPS (diluted)$0.45+137%

Balance sheet

See full

Cash & equivalents$35.0M-1.3%

Total debt$862.6M-3.6%

Total equity$1.0B+4.1%

Total assets$2.3B+0.8%

Cash flow

See full

Operating cash flow$13.5M-67.6%

CapEx$2.9M-23.5%

Free cash flow$10.6M-72.0%

Valuation

See full

Market cap$1.04B-35.6%

Enterprise value$1.87B-24.5%

P/E19×+5.4×

P/S0.8×-0.5×

Profitability

See full

Gross margin55.2%-1.0pp

Operating margin8.2%-5.6pp

Net margin4%-5.0pp

FCF margin9%-3.5pp

Returns & leverage

See full

Return on equity5.5%-7.5pp

Debt / equity0.8×-0.1×

Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's unrealized gains (losses) on hedge instruments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CONMED's unrealized gains (losses) on hedge instruments?: CONMED (CNMD) reported unrealized gains (losses) on hedge instruments of $3.06M in Q1 2026.
How has CONMED's unrealized gains (losses) on hedge instruments changed year-over-year?: CONMED's unrealized gains (losses) on hedge instruments increased by 183.4% year-over-year, from -$3.67M to $3.06M.